Selected research
Industry Growth & Trends
Global Veterinary Drugs Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Veterinary Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Veterinary Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Veterinary Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Veterinary Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Veterinary Drugs market include Zoetis Inc., Merck Animal Health, Bayer AG, Virbac SA, Vetoquinol SA, IDEXX Laboratories, Inc., Elanco, Covetrus, Inc. and Ceva Sante Animale S.A., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Veterinary Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Veterinary Drugs market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Veterinary Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Veterinary Drugs.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Veterinary Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Veterinary Drugs Market by Company
Zoetis Inc.
Merck Animal Health
Bayer AG
Virbac SA
Vetoquinol SA
IDEXX Laboratories, Inc.
Elanco
Covetrus, Inc.
Ceva Sante Animale S.A.
Boehringer Ingelheim Animal Health
Veterinary Drugs Segment by Type
Treatment Drugs
Vaccines
Others
Veterinary Drugs Segment by Application
Chickens
Cattle
Swine
Others
Veterinary Drugs Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Veterinary Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Veterinary Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Veterinary Drugs.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Veterinary Drugs companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Treatment Drugs
- Vaccines
- Others
Applications
- Chickens
- Cattle
- Swine
- Others
Companies covered
- Zoetis Inc.
- Merck Animal Health
- Bayer AG
- Virbac SA
- Vetoquinol SA
- IDEXX Laboratories, Inc.
- Elanco
- Covetrus, Inc.
- Ceva Sante Animale S.A.
- Boehringer Ingelheim Animal Health
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Veterinary Drugs Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Veterinary Drugs Market Size by Region (2021-2032)
- 1.4.1 Global Veterinary Drugs Market Size by Region (2021-2026)
- 1.4.2 Global Veterinary Drugs Market Size by Region (2027-2032)
- 1.5 Key Regions Veterinary Drugs Market Size (2021-2032)
- 1.5.1 North America Veterinary Drugs Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Veterinary Drugs Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Veterinary Drugs Market Size Growth Rate (2021-2032)
- 1.5.4 South America Veterinary Drugs Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Veterinary Drugs Market Size Growth Rate (2021-2032)
2 Veterinary Drugs Market by Type
- 2.1 Type Introduction
- 2.1.1 Treatment Drugs
- 2.1.2 Vaccines
- 2.1.3 Others
- 2.2 Global Veterinary Drugs Market Size by Type
- 2.2.1 Global Veterinary Drugs Market Size Overview by Type (2021-2032)
- 2.2.2 Global Veterinary Drugs Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Veterinary Drugs Market Size Forecasted by Type (2027-2032)
- 2.3 Global Veterinary Drugs Market Size by Regions
- 2.3.1 North America Veterinary Drugs Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Veterinary Drugs Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Veterinary Drugs Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Veterinary Drugs Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Veterinary Drugs Market Size Breakdown by Type (2021-2026)
3 Veterinary Drugs Market by Application
- 3.1 Type Introduction
- 3.1.1 Chickens
- 3.1.2 Cattle
- 3.1.3 Swine
- 3.1.4 Others
- 3.2 Global Veterinary Drugs Market Size by Application
- 3.2.1 Global Veterinary Drugs Market Size Overview by Application (2021-2032)
- 3.2.2 Global Veterinary Drugs Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Veterinary Drugs Market Size Forecasted by Application (2027-2032)
- 3.3 Global Veterinary Drugs Market Size by Regions
- 3.3.1 North America Veterinary Drugs Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Veterinary Drugs Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Veterinary Drugs Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Veterinary Drugs Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Veterinary Drugs Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Veterinary Drugs Industry Trends
- 4.2 Veterinary Drugs Industry Drivers
- 4.3 Veterinary Drugs Industry Opportunities and Challenges
- 4.4 Veterinary Drugs Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Veterinary Drugs Revenue (2021-2026)
- 5.2 Global Veterinary Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Veterinary Drugs Key Company Headquarters & Area Served
- 5.4 Global Veterinary Drugs Company, Product Type & Application
- 5.5 Global Veterinary Drugs Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Veterinary Drugs Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Veterinary Drugs Players Market Share by Revenue in 2025
- 5.6.3 2025 Veterinary Drugs Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Zoetis Inc.
- 6.1.1 Zoetis Inc. Company Information
- 6.1.2 Zoetis Inc. Business Overview
- 6.1.3 Zoetis Inc. Veterinary Drugs Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Zoetis Inc. Veterinary Drugs Product Portfolio
- 6.1.5 Zoetis Inc. Recent Developments
- 6.2 Merck Animal Health
- 6.2.1 Merck Animal Health Company Information
- 6.2.2 Merck Animal Health Business Overview
- 6.2.3 Merck Animal Health Veterinary Drugs Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Merck Animal Health Veterinary Drugs Product Portfolio
- 6.2.5 Merck Animal Health Recent Developments
- 6.3 Bayer AG
- 6.3.1 Bayer AG Company Information
- 6.3.2 Bayer AG Business Overview
- 6.3.3 Bayer AG Veterinary Drugs Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Bayer AG Veterinary Drugs Product Portfolio
- 6.3.5 Bayer AG Recent Developments
- 6.4 Virbac SA
- 6.4.1 Virbac SA Company Information
- 6.4.2 Virbac SA Business Overview
- 6.4.3 Virbac SA Veterinary Drugs Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Virbac SA Veterinary Drugs Product Portfolio
- 6.4.5 Virbac SA Recent Developments
- 6.5 Vetoquinol SA
- 6.5.1 Vetoquinol SA Company Information
- 6.5.2 Vetoquinol SA Business Overview
- 6.5.3 Vetoquinol SA Veterinary Drugs Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Vetoquinol SA Veterinary Drugs Product Portfolio
- 6.5.5 Vetoquinol SA Recent Developments
- 6.6 IDEXX Laboratories, Inc.
- 6.6.1 IDEXX Laboratories, Inc. Company Information
- 6.6.2 IDEXX Laboratories, Inc. Business Overview
- 6.6.3 IDEXX Laboratories, Inc. Veterinary Drugs Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 IDEXX Laboratories, Inc. Veterinary Drugs Product Portfolio
- 6.6.5 IDEXX Laboratories, Inc. Recent Developments
- 6.7 Elanco
- 6.7.1 Elanco Company Information
- 6.7.2 Elanco Business Overview
- 6.7.3 Elanco Veterinary Drugs Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Elanco Veterinary Drugs Product Portfolio
- 6.7.5 Elanco Recent Developments
- 6.8 Covetrus, Inc.
- 6.8.1 Covetrus, Inc. Company Information
- 6.8.2 Covetrus, Inc. Business Overview
- 6.8.3 Covetrus, Inc. Veterinary Drugs Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Covetrus, Inc. Veterinary Drugs Product Portfolio
- 6.8.5 Covetrus, Inc. Recent Developments
- 6.9 Ceva Sante Animale S.A.
- 6.9.1 Ceva Sante Animale S.A. Company Information
- 6.9.2 Ceva Sante Animale S.A. Business Overview
- 6.9.3 Ceva Sante Animale S.A. Veterinary Drugs Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Ceva Sante Animale S.A. Veterinary Drugs Product Portfolio
- 6.9.5 Ceva Sante Animale S.A. Recent Developments
- 6.10 Boehringer Ingelheim Animal Health
- 6.10.1 Boehringer Ingelheim Animal Health Company Information
- 6.10.2 Boehringer Ingelheim Animal Health Business Overview
- 6.10.3 Boehringer Ingelheim Animal Health Veterinary Drugs Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 Boehringer Ingelheim Animal Health Veterinary Drugs Product Portfolio
- 6.10.5 Boehringer Ingelheim Animal Health Recent Developments
7 North America
- 7.1 North America Veterinary Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Veterinary Drugs Market Size by Country (2021-2026)
- 7.3 North America Veterinary Drugs Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Veterinary Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Veterinary Drugs Market Size by Country (2021-2026)
- 8.3 Europe Veterinary Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Veterinary Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Veterinary Drugs Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Veterinary Drugs Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Veterinary Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Veterinary Drugs Market Size by Country (2021-2026)
- 10.3 South America Veterinary Drugs Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Veterinary Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Veterinary Drugs Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Veterinary Drugs Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst